
Pharmacally
Hepatitis B
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Hepatitis B
New Drug ApprovalHibsago (Bepirovirsen) Approved in Japan as First Functional Cure Treatment for Chronic Hepatitis BJapan has approved GSK’s Hibsago (bepirovirsen) as a functional cure treatment for eligible adults with chronic hepatitis B, marking the first global approval of the antisense oligonucleotide.Fact-Checked
Health TidingsGSK advances bepirovirsen with FDA priority review in hepatitis BThe FDA has granted priority review to GSK’s investigational hepatitis B therapy bepirovirsen, following Phase III results demonstrating significantly higher functional cure rates compared with standard treatment alone.Fact-Checked
Health TidingsGSK’s Bepirovirsen Accepted by EMA for Review in Chronic Hepatitis BThe European Medicines Agency has accepted GSK plc’s filing for bepirovirsen in chronic hepatitis B, backed by Phase III B-Well trials demonstrating significantly higher functional cure rates versus…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.